Jeffrey Percak

Jeffrey Percak

Auto-generated profile, based on publicly available information

Jeffrey Percak

Tulane University School of Medicine, New Orleans, LA, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
SFSamuel C. Ficenec
Samuel C. Ficenec
JPJeffrey Percak
Jeffrey Percak
SASara Arguello
Sara Arguello
ABAlison Bays
Alison Bays
AGAugustine Goba
Augustine Goba
DBDaniel Bausch
Daniel Bausch
Lassa fever (LF), a hemorrhagic fever endemic to West Africa, has an incidence of approximately 500,000 cases per year. This study evaluated hearing loss and other sequelae following LF. This case–control study enrolled laboratory-confirmed LF survivors, non-LF febrile controls and matched-community controls with no history of LF or recent hospitalization for a febrile illness. Study participants completed a symptom questionnaire. Pure-tone audiometry was completed by a subset of participants. A total of 147 subjects aged 3–66 years (mean, 23.3) were enrolled. LF survivors were significantly more likely to report balance difficulties (55% vs. 20%, p < 0.001), hair loss (32% vs. 7%, p < 0.001), difficulty speaking (19% vs. 1%, p < 0.001), social isolation (50% vs. 0%, p < 0.001), and hearing loss (17% vs. 1%, p = 0.002) in comparison with matched-community controls. Similar trends were noted in comparison with febrile controls, although these findings were non-significant. Fifty subjects completed audiometry. Audiometry found that LF survivors had significantly more bilateral hearing loss in comparison with matched-community controls (30% vs. 4%, p = 0.029). This study characterized the sequelae of LF and highlighted the need for increased access to hearing care in West Africa.